Delivery Order SPE2DB22D3501-SPE2DB25FVP24
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,566.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a medication, with a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business classification. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $26,890.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML" and is a firm fixed-price delivery order without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $7,977.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,123.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a performance period through May 2025. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $1,711.67, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award, valued at $1,949.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" with a completion date of March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, worth $1,157.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, and has an ultimate completion date of March 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,613.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a performance period through May 5, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,792.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4568062174 - ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of April 29, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,143.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML" medication. The contract is not designated as a set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also holds a significant...